Introduction {#sec1}
============

Total knee arthroplasty (TKA) is an effective procedure for alleviating pain and improving activities of daily living (ADL) in patients with end-stage osteoarthritis of the knee.[@bib1] However, postoperative limitations in the range of motion (ROM) may occur occasionally and restrict a patient's ADL.[@bib1]^,^[@bib2] The ROM after TKA is reported to be strongly influenced by the preoperative ROM.[@bib3]^,^[@bib4] It has also been reported that the postoperative ROM is influenced by nerve block, changes in ligament balance in the knee joint, accurate implant positioning and by the implant design adopted[@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10] and the improved ROM after TKA affect the patient function and satisfaction.[@bib11]

Although ROM exercise is known to be a means of increasing the ROM after TKA[@bib1]^,^[@bib12] and starting early rehabilitation within 24 h have benefits for the early recovery,[@bib13]^,^[@bib14] the optimal time of initiating only ROM exercise has not been discussed in the literature; it still remains to be unclear and varies per institution. In particular, it has been reported that local inflammation and swelling may occur in an early stage after TKA[@bib15], [@bib16], [@bib17]; therefore, we speculated and hypothesized that ROM exercises beginning in the early postoperative stage are disadvantageous in restoring the ROM and relieving pain postoperatively, for eliciting local inflammation and swelling. However, there has been no report that denied the propriety of ROM exercise during the early postoperative stage.

In this study, we aimed to examine different initiation timings of postoperative ROM exercises after TKA and to compare the results in terms of postoperative pain, swelling, and ROM improvement to determine the optimal time of initiating ROM exercises following TKA.

Materials & methods {#sec2}
===================

This study was a prospective, single-center, single-blinded randomized controlled trial. The study protocol was approved by the institutional review board. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The trial was registered as a randomized controlled trial with the University Hospital Medical Information Network (UMIN) registration number UMIN000020298.

Study population {#sec2.1}
----------------

This study focused on patients who underwent unilateral TKAs from March 2016 to August 2017. Patients with renal insufficiency, a history of cardiac disease, deep vein thrombosis, or surgery of the knee joint were excluded, and 120 patients were eligible for the study. We excluded patients who were scheduled for simultaneous or staged bilateral TKA (n = 10) or for revision TKA (n = 1). Finally, 109 patients (89 women and 20 men) were included for the study. The flowchart for patient selection for the study is presented in [Fig. 1](#fig1){ref-type="fig"}.Fig. 1CONSORT (consolidated Standards of Reporting Trials) flow diagram, showing the flow of patients through each stage of the trial.Fig. 1

Interventions {#sec2.2}
-------------

Before admission, the patients were randomly divided into 2 groups using the envelope method. (1) patients who started the postoperative ROM exercises on postoperative day 1 (Day 1 group: n = 55) and (2) patients who started the postoperative ROM exercises on postoperative day 7 (Day 7 group: n = 54). A staff member who did not participate in this study performed the envelope selection. All patients underwent the physiotherapist assisted passive and active hospital-based rehabilitation program that only differed in the starting time of ROM exercise until 3 months postoperatively. The rehabilitation program consisted of walking with a walker starting at day 1 after TKA and walking with a T-shaped cane and climbing and descending stairs starting at day 7 after TKA. Patients in Day 7 group did not have any active and passive ROM exercises until postoperative day 6. The operating surgeon, ward nursing staff, and data collectors, excluding patients and physiotherapists, remained blinded for the whole duration of the trial.

Both groups performed flexion and extension of the knee joint on the affected side (30-min training by a physiotherapist in each day, combined with permitted self-training), but with different starting time (1 or 7 days after TKA).

Perioperative medications {#sec2.3}
-------------------------

The following postoperative analgesic medications were administered in both groups. A nonsteroidal anti-inflammatory drug (200 mg of celecoxib; Astellas Pharma Inc., Tokyo, Japan) was taken twice a day for the first 7 days; for the remaining 14 days, the dose was decreased to 100 mg of celecoxib. The diclofenac sodium suppository (25 mg of Voltaren; Novartis, Tokyo, Japan) was used for rescue analgesia.

No thromboprophylaxis was provided except for lower-leg stocking and foot pump.

Surgery {#sec2.4}
-------

All surgery were performed by one of the two surgeons (KI and AK) with a medial parapatellar approach under general anesthesia. A pneumatic tourniquet was treated in all patients with the pressure of 300 mmHg during surgery. The implants used were cemented cruciate-substituting devices (Physio Knee; Kyocera, Kyoto, Japan/GMK Sphere; Medacta, Switzerland) for 50/19 knees and cemented posterior-stabilized devices (Vanguard Rotating Platform High Flex; Biomet, Warsaw, IN) for 40 knees \[[Table 1](#tbl1){ref-type="table"}\].Table 1Patient Demographics and baseline characteristics.Table 1ROM Day1 groupROM Day 7 group*p value*(55 patients, 55knees)(54 patients, 54knees)Demographic characteristics Age∗ (yr)75.0 ± 7.375.6 ± 6.20.64† Female/Male45/1044/100.71‡ Right/Left34/2124/300.26‡ Height∗ (cm)154.5 ± 8.7151.8 ± 7.10.06† Weight∗ (kg)59.1 ± 13.758.3 ± 10.80.88† Body mass index∗ (kg/m2)24.5 ± 4.225.2 ± 3.70.28† Osteoarthritis/spontaneous osteonecrosis54/153/1-- Hip-Knee-Ankle angle∗ (deg)7.4 ± 5.59.4 ± 7.60.10†Preop. Laboratory values Hemoglobin∗ (g/dl)13.0 ± 1.413.1 ± 1.40.54† C-reactive protein∗ (mg/dl)0.30 ± 0.880.26 ± 0.720.76† Creatinine Kinase∗ (mg/dl)102.8 ± 48.1112.2 ± 59.20.39† D-dimer∗ (mg/ml)1.5 ± 1.31.7 ± 1.60.75†Preop. status Preoperative VAS score at rest∗15.7 ± 24.29.5 ± 15.70.11† Preoperative flexion angle∗ (deg)125.7 ± 13.1123.7 ± 14.30.21† Preoperative extension angle∗ (deg)−8.6 ± 6.0−10.3 ± 4.90.11† Preoperative WOMAC score∗38.3 ± 20.943.7 ± 16.10.16†Operative status CS/PS35/2034/200.99‡ Estimated blood loss∗ (ml)494.6 ± 282.2466.1 ± 305.40.66† Duration of surgery∗ (min)82.0 ± 21.878.2 ± 14.30.39†[^1]

Intraoperative periarticular cocktail injection was used for the postoperative pain relief that Iwakiri et al. have previously reported.[@bib18]^,^[@bib19] Tranexamic acid (Transamin; Daiichi-Sankyo, Tokyo, Japan) was used intravenously at 1 g before surgery and into the joint capsule at a dose of 2 g after the suture of the joint capsule as a prophylaxis for perioperative bleeding.[@bib18]^,^[@bib19] No drainage tube was used. To alleviate postoperative swelling, cryotherapy was treated at 5 °C for 72 h immediately after surgery, and the patients were instructed to wear the cryotherapy device whenever on bed.

Outcome measurements {#sec2.5}
--------------------

### Primary outcomes {#sec2.5.1}

The primary outcomes included the visual analog pain score (VAS) at rest (preoperatively, every 3 h from 3 to 24 h from time zero immediately after surgery, every 8 h from 24 to 72 h, and on postoperative days 7 and 14).

The VAS score was shown from 0 mm (indicating no pain) to 100 mm (indicating extreme pain) in 10-mm increments. The amount of using diclofenac sodium suppository for the rescue analgesia was also measured.

### Secondary outcomes {#sec2.5.2}

The secondary outcome measures evaluated were the laboratory data (C-reactive protein, creatinine kinase, hemoglobin level: preoperatively and on postoperative days 1, 4, 7, and 14; D-dimer: preoperatively and on postoperative days 7 and 21), the estimated blood loss, the ROM of the knee (preoperatively and on postoperative days 7, 14, 21, 28 and 3 months, and 1--2 year), and thigh swelling (two points; thigh circumference at the superior border of the patella and 5-cm proximal from the superior border of the patella: preoperatively and on postoperative days 7, 14, and 21), the WOMAC Index (preoperatively and 3 months and 1--2 year postoperatively),[@bib20] and adverse complications, including wound complications, surgical site infection, peroneal nerve palsy, and deep venous thrombosis, during this study. The estimated blood loss was calculated using the Nadler formula.[@bib21] The ratio of the postoperative thigh circumference divided by the preoperative thigh circumference was calculated for comparing the thigh swelling between two groups.[@bib18]^,^[@bib19]

### Sample size {#sec2.5.3}

We considered a reduction of 20 points in the VAS pain scale score to be the relevant minimal clinically important difference after TKA. We needed 43 patients per each group to detect a mean difference and standard deviation of 20 ± 33 points in the VAS pain score with a two-sided 5% significance level and 80% power.[@bib18]^,^[@bib22]

### Statistical analysis {#sec2.5.4}

To analyze the primary and secondary outcomes, the Student T test for continuous variables and the chi-square test for categorical variables were used for the comparison between two groups. The p value of less than 0.05 was considered to indicate a statistically significant difference. SPSS statistics version 22.0 (IBM Corp., US) was used for all statistical analyses.

Results {#sec3}
=======

The demographic characteristics of the patients in both groups are summarized in [Table 1](#tbl1){ref-type="table"}. The mean age of all patients at operation was 75.3 ± 6.8 years. The preoperative diagnosis was osteoarthritis of the knee in 107 patients and spontaneous osteonecrosis of the knee in two patients. Between the two groups, there was no significant difference in age, sex, BMI, diagnosis, preoperative laboratory data, preoperative status (VAS score at rest, preoperative ROM, and WOMAC), Hip-Knee-Ankle angle[@bib23] or operative status (implant, estimated blood loss, and duration of surgery).

Primary outcomes {#sec3.1}
----------------

The VAS scores at rest from 18 to 72 h postoperatively (except from 40 to 56h) were significantly lower in the Day 1 group, with starting time of ROM exercise on postoperative day 1 (p \< 0.05) ([Fig. 2](#fig2){ref-type="fig"}). There were no statistically significant differences in the other primary outcomes between the two groups (including total number of rescue analgesia by diclofenac sodium suppository in [Table 2](#tbl2){ref-type="table"}).Fig. 2Pain VAS score at rest (mean and standard deviation) following total knee arthroplasty in the two groups. Time zero is defined as the time immediately after surgery in the recovery room. ∗p \< 0.05.Fig. 2Table 2Primary & secondary outcomes.Table 2ROM Day 1 groupROM Day 7 group*p value*(55 patients, 55 knees)(54 patients, 54 knees)Postop. Laboratory values: Hemogrobin (g/dl)∗ Day 111.8 ± 1.311.8 ± 1.20.6 Day 411.7 ± 1.511.8 ± 1.20.42 Day 711.5 ± 1.511.7 ± 1.40.3 Day 1411.6 ± 1.411.6 ± 2.00.79Postop. Laboratory values: C-reactive protein (mg/dl)∗ Day 10.68 ± 0.830.65 ± 0.760.9 Day 45.78 ± 3.635.48 ± 3.870.78 Day 71.48 ± 1.081.77 ± 1.780.32 Day 140.40 ± 0.410.50 ± 0.480.37Postop. Laboratory values: Creatinine Kinase (mg/dl)∗ Day 1107.3 ± 33.3115.3 ± 47.30.36 Day 492.3 ± 40.7107.2 ± 54.40.11 Day 768.1 ± 36.864.8 ± 30.70.63 Day 1459.2 ± 24.756.6 ± 24.30.73Postop. Laboratory values: D-dimer (mg/mL)∗ Day 77.1 ± 3.56.8 ± 3.20.34 Day 217.4 ± 3.08.6 ± 5.40.14Total number of rescue analgesia by suppositories∗ Day 0 to Day 20.71 ± 1.491.02 ± 2.110.37Postop. WOMAC score∗ 3 months19.1 ± 16.815.0 ± 10.30.35† 1 year15.6 ± 16.313.4 ± 8.60.56† 2 years13.3 ± 13.112.5 ± 12.70.76†Complications Surgical site infection‡00-- Wound problem‡00-- Transient peroneal nerve palsy‡00-- Deep vain thrombosis‡00--[^2]

Secondary outcomes {#sec3.2}
------------------

There were no statistically significant differences in all secondary outcome between the two groups (including laboratory data in [Table 2](#tbl2){ref-type="table"}, and ROM and thigh swelling in [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}). There were no cases with surgical site infection, peroneal nerve palsy or deep venous thrombosis in either group ([Table 2](#tbl2){ref-type="table"}).Fig. 3Knee flexion and extension (mean and standard deviation) following total knee arhtoplasty in the two groups.Fig. 3Fig. 4(a) Ratio of the thigh circumference at the patella superior border following total knee arthroplasty. (b) Ratio of the thigh circumference at 5-cm proximal from the patella superior border following total knee arthroplasty.Fig. 4

Discussion {#sec4}
==========

The remarkable findings of this study were that the postoperative pain was significantly reduced in patients who started the ROM exercises on postoperative day 1 (Day 1 group) than in those who started on postoperative day 7 (Day 7 group), and the initiating early ROM exercise within 24 h did not adversely affect swelling, ROM or WOMAC score after surgery.

It has been reported that limited ROM following TKA may restrict ADL and decrease patient satisfaction.[@bib1]^,^[@bib2] Therefore, having a sufficient ROM following TKA, as well as alleviating pain, is a very important factor in increasing patient satisfaction.

The ROM after TKA is reported to be largely influenced by the preoperative ROM.[@bib3]^,^[@bib4] Especially, it is considered difficult to achieve a marked improvement in ROM postoperatively in patients who have a poor ROM preoperatively. However, measures available to achieve sufficient improvement in ROM include proper implant selection, adjustment of soft tissue balance, use of navigation, removal of bone spurs, adequate implant positioning, rehabilitation methods, and continuous passive motions.[@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10]^,^[@bib24], [@bib25], [@bib26], [@bib27] It has also been reported that initiation of physiotherapy in an early postoperative stage leads to improvement in postoperative motor function.[@bib28] However, there has been no report about the optimal time to initiate the only ROM exercise. Given that local inflammation and swelling reportedly occur during the early postoperative stage, we speculated that ROM exercise initiated during the early postoperative stage may induce further inflammation and swelling of the local tissue around the knee joint, resulting in adverse effects on the postoperative process of restoration of ROM.[@bib15], [@bib16], [@bib17] However, in this randomized controlled trial, thigh swelling, postoperative ROM and WOMAC score were not adversely affected in the group with an early start of postoperative ROM exercise (on postoperative day 1) compared with the group with ROM exercises started on postoperative day 7.

The postoperative pain was significantly decreased in the group with ROM exercise starting on postoperative day 1. Postoperative adhesions are generally known to start immediately after surgery and end on postoperative day 7.[@bib29]^,^[@bib30] Surgically damaged tissue emits fibrin, macrophages, and fibroblasts in the recovery process of inflammation. Fibroblasts begin to form fibrous tissue in postoperative day 2--3, followed by the appearance of angiogenesis and neuroblasts, and fibrous tissue organize and adhere in postoperative day 5--7. Starting ROM exercise within 24 h after surgery might have prevented the occurrence of postoperative adhesion around the knee joint, contributing to amelioration of pain. All the participants in this study underwent intraoperative multimodal periarticular injection for potent analgesic effect, lasting for about 48--72 h.[@bib18]^,^[@bib19]^,^[@bib31] Therefore, early postoperative pain may be less susceptible by the early ROM exercise.

According to the results of this study, the initiating ROM exercise within 24 h after surgery is recommended for the postoperative pain relief.

Study limitations {#sec4.1}
-----------------

There are several limitations to this study. First, because intraoperative multimodal periarticular injection, intra-articular and intravenous tranexamic acid, and post-operative cryotherapy were administered to prevent postoperative swelling and blood loss and to reduce the postoperative pain, the mild degree of swelling may have made it difficult to detect the effect of ROM exercise. Second, the patients were not blinded to the timing of initiating the ROM exercise because of the characteristics of this study. There might be any mental conflict existed between the groups. Third, there might be a bias in measuring the VAS score at each point by several nurses. Fourth, there is a report about Minimal Clinically Important Difference (MCID) as a clinical significance of VAS score.[@bib32] The difference in VAS score in this study may not be clinically significant from the MCID perspective. The advantage of the study was that the operating surgeons, ward nursing staff, and data collectors remained blinded to the groups' status during the whole study duration.

Conclusions {#sec5}
===========

Our data show that there was no difference in swelling or postoperative range of knee motion between patients who started ROM exercises on postoperative day 1 and those who started on postoperative day 7. However, postoperative pain was significantly reduced in patients who started the ROM exercises on postoperative day 1 than in those who started on postoperative day 7, indicating the benefit of starting ROM exercises during the early postoperative stage. The ROM exercises beginning in the early postoperative stage might be advantageous in reducing the postoperative pain after TKA.
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[^1]: ∗ The values are given as the mean and standard deviation. † The p values were determined with the Student T-test. ‡The p values were determined with the chi-square test.

[^2]: ∗ The values are given as the mean and standard deviation. † The p values were determined with the Student T-test. ‡The values are expressed as the number of patients.
